跳至主要内容
临床试验/EUCTR2015-003504-22-IE
EUCTR2015-003504-22-IE进行中(未招募)1 期

The NAPRESSIM trial.The use of low dose prophylactic naloxone infusion to prevent respiratory depression with intrathecal morphine.

CD0 个研究点目标入组 84 人开始时间: 2015年8月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CD
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients >18 years of age
  • Capable of giving informed consent.
  • Undergoing elective open hepatic resection, pancreatectomy or partial pancreatectomy, or other open major hepatobiliary surgery in St Vincents University Hospital.
  • Consenting to standard anaesthetic and analgesic regimen in the hepatobiliary unit.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 67
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 17

排除标准

  • Chronic opioid use
  • <18 years of age
  • Major Psychiatric illness
  • Epilepsy with recent seizures
  • Personal history of adverse reaction to naloxone or any of its derivatives
  • Contraindication to neuraxial injection
  • Obstructive sleep apnoea

研究者

发起方
CD

相似试验